Most Read News

For the quarter ended June 30, 2025, Aster reported a consolidated revenue of ₹1,078 crore. This is up 8% from ₹1,002 crore in the same period last year.

On the other hand, EBITDA for the quarter stood at ₹3,718 Crore. This was marginally down against ₹3,744 Crore in the previous corresponding period.

At around 12.53 PM, Orchid Pharma was trading 5% higher at ₹740.40, against the previous close of ₹705.15 on NSE.

Earlier this month, it had received a much larger contract valued at ₹105 crore for the supply of defence-grade explosives to overseas clients.

While the year-on-year performance was solid, the company faced a setback on a sequential basis.

Net profit also rose 20% year-on-year to ₹157 crore, largely helped by a strong jump in other income, which increased to ₹236 crore from ₹143 crore in the same quarter last year.

EBITDA jumped 172% to ₹105 crore during the quarter. This is up from ₹39 crore a year ago.

ICICI Bank hits 52-week high in Sensex. TCS hits 52-week low in Sensex. 

Following the transaction, Tata Motors has agreed to uphold certain non-financial commitments related to employment and operations for at least two years after the deal closes.

Operating performance was particularly robust. EBITDA for the quarter stood at ₹1,961 crore.